Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call for Papers: Neuroinflammation in the Retina

We are proud to present a new Collection that seeks to discover novel immune mechanisms in the diseased retina to offer novel diagnostic markers or highlight targets for immuno-modulatory therapies that could help to reduce the burden of vision loss worldwide.

Read More

Call for Papers: Neuroimmune and Neuroinflammatory Mechanisms in Traumatic Brain Injury

Journal of Neuroinflammation is presenting a new Collection of articles that will explore novel functional mechanisms after a traumatic brain injury with an eye towards elucidating and modifying the pathogenic progression to the various post-traumatic syndromes.

Read More


Top 10: Most Cited Articles of 2019 and 2020

Neuroinflammation: friend and foe for ischemic stroke
Richard L. Jayaraj, Sheikh Azimullah, Rami Beiram, Fakhreya Y. Jalal, & Gary A. Rosenberg  

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Qianquan Ma, Changsheng Xing, Wenyong Long, Helen Y. Wang, Qing Liu, & Rong-Fu Wang

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease 
Lin, CH., Chen, CC., Chiang, HL. et al 

The endotoxin hypothesis of neurodegeneration
Guy C. Brown 

Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles
Sylwia Dabrowska, Anna Andrzejewska, Barbara Lukomska, & Miroslaw Janowski 

Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
Liu, W., Rong, Y., Wang, J. et al. 

The progress of gut microbiome research related to brain disorders
Sibo Zhu, Yanfeng Jiang, Kelin Xu, Mei Cui, Weimin Ye, Genming Zhao, Li Jin, & Xingdong Chen 

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Zusso, M., Lunardi, V., Franceschini, D. et al.

Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports
Najjar, S., Najjar, A., Chong, D.J. et al. 

Glial activation and inflammation along the Alzheimer’s disease continuum
Nordengen, K., Kirsebom, BE., Henjum, K. et al. 

Aims and scope

Journal of Neuroinflammation is a fully open access journal that focuses on interactions of the immune system (and especially the innate immune system) with the nervous system. Read more


Monica J Carson, University of California, Riverside, USA
Sue T Griffin, University of Arkansas for Medical Sciences, USA

Reasons to publish with us

  • Top-ranking journal focusing on the innate immunological response of the nervous system
  • High-quality peer review
  • High visibility for your work: freely accessible to all

Springer Nature's Response to Black Lives Matter

A statement by our CEO Frank Peeters can be found here

The company has also compiled a collection of books, journal articles and magazine content that amplifies Black voices and the issues raised by the Black Lives Matter movement which can be found here

Announcing the launch of In Review

Journal of Neuroinflammation, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.8 - 5-year Impact Factor
    1.792 - SNIP (Source Normalized Impact per Paper)
    2.439 - SJR (SCImago Journal Rank)

    2022 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    145 days submission to accept (Median)

    2022 Usage 
    8,005 Altmetric mentions